Free Trial

Mvm Partners, Llc Sells 27,142 Shares of Paragon 28, Inc. (NYSE:FNA) Stock

Paragon 28 logo with Medical background

Paragon 28, Inc. (NYSE:FNA - Get Free Report) major shareholder Mvm Partners, Llc sold 27,142 shares of the firm's stock in a transaction on Monday, January 27th. The stock was sold at an average price of $11.62, for a total transaction of $315,390.04. Following the completion of the sale, the insider now owns 10,313,841 shares in the company, valued at $119,846,832.42. This represents a 0.26 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Major shareholders that own 10% or more of a company's stock are required to disclose their sales and purchases with the SEC.

Mvm Partners, Llc also recently made the following trade(s):

  • On Thursday, January 23rd, Mvm Partners, Llc sold 20,136 shares of Paragon 28 stock. The shares were sold at an average price of $11.63, for a total value of $234,181.68.
  • On Wednesday, December 4th, Mvm Partners, Llc sold 18,109 shares of Paragon 28 stock. The shares were sold at an average price of $10.14, for a total value of $183,625.26.
  • On Wednesday, November 27th, Mvm Partners, Llc sold 4,256 shares of Paragon 28 stock. The stock was sold at an average price of $10.00, for a total value of $42,560.00.
  • On Monday, November 25th, Mvm Partners, Llc sold 10,835 shares of Paragon 28 stock. The shares were sold at an average price of $10.09, for a total transaction of $109,325.15.
  • On Friday, November 22nd, Mvm Partners, Llc sold 72,133 shares of Paragon 28 stock. The stock was sold at an average price of $10.16, for a total transaction of $732,871.28.
  • On Wednesday, November 20th, Mvm Partners, Llc sold 147,581 shares of Paragon 28 stock. The shares were sold at an average price of $10.28, for a total transaction of $1,517,132.68.

Paragon 28 Price Performance

Shares of FNA traded down $0.01 on Friday, hitting $13.03. The company's stock had a trading volume of 2,052,850 shares, compared to its average volume of 1,525,951. The company has a 50 day moving average price of $10.65 and a 200 day moving average price of $8.46. Paragon 28, Inc. has a fifty-two week low of $4.65 and a fifty-two week high of $14.79. The company has a market capitalization of $1.09 billion, a PE ratio of -17.60 and a beta of 1.50. The company has a debt-to-equity ratio of 0.79, a current ratio of 3.50 and a quick ratio of 1.60.

Paragon 28 (NYSE:FNA - Get Free Report) last posted its quarterly earnings data on Tuesday, November 12th. The company reported ($0.15) EPS for the quarter, topping analysts' consensus estimates of ($0.16) by $0.01. Paragon 28 had a negative return on equity of 37.90% and a negative net margin of 25.31%. The company had revenue of $62.30 million for the quarter, compared to analyst estimates of $60.58 million. During the same quarter in the previous year, the firm earned ($0.10) earnings per share. The business's revenue was up 18.0% on a year-over-year basis. On average, research analysts anticipate that Paragon 28, Inc. will post -0.64 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of research analysts have commented on the stock. Canaccord Genuity Group restated a "hold" rating on shares of Paragon 28 in a research note on Wednesday. Needham & Company LLC restated a "hold" rating and set a $13.00 target price on shares of Paragon 28 in a research report on Wednesday. Stephens reiterated an "equal weight" rating and issued a $13.00 price target (down from $14.00) on shares of Paragon 28 in a research report on Thursday. Finally, William Blair lowered Paragon 28 from an "outperform" rating to a "market perform" rating in a research note on Wednesday. Four research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat, Paragon 28 currently has an average rating of "Hold" and an average target price of $14.60.

Get Our Latest Report on FNA

Institutional Investors Weigh In On Paragon 28

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Rhumbline Advisers lifted its position in shares of Paragon 28 by 1.7% during the fourth quarter. Rhumbline Advisers now owns 62,861 shares of the company's stock worth $649,000 after purchasing an additional 1,024 shares in the last quarter. MN Wealth Advisors LLC lifted its holdings in Paragon 28 by 1.4% during the 4th quarter. MN Wealth Advisors LLC now owns 84,535 shares of the company's stock worth $873,000 after buying an additional 1,200 shares in the last quarter. Ballentine Partners LLC lifted its holdings in Paragon 28 by 15.0% during the 4th quarter. Ballentine Partners LLC now owns 15,630 shares of the company's stock worth $161,000 after buying an additional 2,043 shares in the last quarter. The Manufacturers Life Insurance Company boosted its position in Paragon 28 by 9.0% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 25,992 shares of the company's stock valued at $178,000 after buying an additional 2,142 shares during the last quarter. Finally, Venturi Wealth Management LLC acquired a new stake in shares of Paragon 28 in the 4th quarter valued at $36,000. Institutional investors and hedge funds own 63.57% of the company's stock.

About Paragon 28

(Get Free Report)

Paragon 28, Inc develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems.

See Also

Insider Buying and Selling by Quarter for Paragon 28 (NYSE:FNA)

Should You Invest $1,000 in Paragon 28 Right Now?

Before you consider Paragon 28, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Paragon 28 wasn't on the list.

While Paragon 28 currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own in 2025 Cover

Enter your email address and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Will it Spark a Rally or Trigger a Sell-Off?
Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock
The EXACT Date of Next Stock Market Crash

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines